Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Endocrinology · Acromegaly

Managing Your Health After Treatment

At a Glance

After acromegaly treatment, normal hormone levels do not end follow-up. Regular IGF-1 testing and pituitary MRI, plus checks of heart health, bones, sleep apnea, colon health, other hormones, and emotional well-being, help detect persistent problems or recurrence.

Achieving “biochemical control”—where your hormone levels reach the normal range—is a major milestone, but it is not the end of your care. Acromegaly is a systemic disease that can leave lasting imprints on your body even after the tumor is treated [1][2]. Long-term management requires a shift from focusing only on the tumor to a lifelong “surveillance” mindset that protects your heart, bones, and overall quality of life.

Post-Treatment Safety: When to Seek Urgent Help

After transsphenoidal surgery, or while managing your condition, there are certain symptoms that require urgent medical attention. Your clinician should give you specific instructions, but generally, seek urgent help for:

  • New visual loss or double vision
  • Severe or worsening headache
  • Clear watery fluid dripping from your nose (a possible cerebrospinal fluid / CSF leak)
  • Fever or neck stiffness (possible infection)
  • Marked thirst and excessive urination (possible diabetes insipidus)
  • Vomiting, faintness, confusion, or profound weakness (possible delayed sodium disturbance or adrenal insufficiency)

The Lifetime Monitoring Schedule

Even if your surgery was successful, you will need regular monitoring to ensure the disease does not return and to catch any new hormone imbalances [3][4].

  • The 3-Month Milestone: About three months after surgery, your team will perform your first “definitive” biochemical assessment, usually checking IGF-1 [3][5].
  • Imaging: A follow-up MRI is typically scheduled 3 to 6 months after surgery to establish a “new baseline” for the pituitary gland [6][2].
  • Annual Checks: Once you are stable, you will typically need IGF-1 blood tests at least once a year [3][5].
  • Other Hormones: Because surgery, radiation, or the tumor itself can affect the healthy parts of your pituitary gland, your doctor will periodically check your thyroid, adrenal, and sex hormones to ensure you haven’t developed hypopituitarism [3][4].

Bone and Joint Health: Managing the “Hidden” Damage

One of the most challenging aspects of acromegaly is that bone and joint changes do not always reverse when hormone levels normalize [7].

  • Arthropathy (Joint Disease): Growth hormone excess can alter the structure of your joints. In some study populations, a high percentage of patients in long-term remission still had radiographic signs of osteoarthritis [7]. While swelling may go down, the underlying bone changes often persist, requiring ongoing physical therapy or pain management [8][9].
  • Vertebral Fractures: Studies estimate roughly one-third of people with acromegaly experience “silent” fractures in the spine (vertebral fractures) [10]. Surprisingly, these can happen even if your bone density (DEXA) scan appears normal. Therefore, evaluation and specialized spine imaging are individualized based on your symptoms and clinician assessment [10][11].

Systemic Comorbidities

Growth hormone affects almost every organ system, necessitating specialized screenings:

  • Cardiovascular Care: High GH levels can cause the heart muscle to thicken (cardiomyopathy) and lead to high blood pressure [12][13]. Even after remission, heart valve changes or hypertension may persist, meaning you may still need blood pressure medication and periodic echocardiograms [14][15].
  • Sleep Apnea: The soft tissue changes in the throat often cause obstructive sleep apnea. While this often improves after treatment, it does not always disappear completely, and some patients require continued use of a CPAP machine [16][17].
  • Colon Health: Because IGF-1 promotes cell growth, people with acromegaly have a higher risk of developing colon polyps [18][19]. A full colonoscopy is recommended at the time of diagnosis, with follow-up intervals tailored to your specific findings and hormone control [18][20].

The Psychological Toll and Quality of Life

Acromegaly changes more than just your labs; it changes how you see yourself and interact with the world. Many patients struggle with body-image distress, anxiety, or depression that persists long after the “physical” disease is controlled [21][22].

Anxiety, depression, body-image distress, and fatigue deserve assessment and treatment in their own right. Do not hesitate to seek urgent mental-health help or access counseling and peer support. To help doctors understand this, they use a specialized tool called the AcroQoL (Acromegaly Quality of Life) questionnaire [23]. It measures how the disease affects your physical function, appearance, and personal relationships [24]. Quality of life is an important, co-equal outcome alongside biochemical control, tumor control, and prevention of complications. If your hormone numbers are “perfect” but you still feel unwell, it is important to speak up [2][22].

Common questions in this guide

How often should IGF-1 be checked after acromegaly treatment?
A first definitive IGF-1 assessment is usually done about three months after surgery. If results remain stable, IGF-1 is generally checked at least once a year, while your clinician may set a different schedule based on your treatment and results.
When is an MRI needed after acromegaly surgery?
A pituitary MRI is commonly scheduled three to six months after surgery to create a new baseline. Further imaging depends on the scan, hormone results, symptoms, and your specialist’s plan.
Can joint and bone problems continue after acromegaly is controlled?
Yes. Joint swelling may improve when hormone levels normalize, but structural joint changes and pain can persist, and vertebral fractures may occur even when a standard bone-density scan, called a DEXA scan, looks normal. Your clinician can decide whether you need physical therapy, pain management, or additional spine imaging.
What health problems should be monitored after acromegaly treatment?
Follow-up may include blood pressure and heart checks, evaluation for sleep apnea, colonoscopy based on your findings and hormone control, and testing of thyroid, adrenal, and sex hormones. These checks look for effects that can persist after treatment, including heart changes, breathing problems, colon polyps, or low pituitary hormone levels.
Why is colonoscopy important for people with acromegaly?
Acromegaly is associated with a higher risk of colon polyps, so a full colonoscopy is recommended at diagnosis. The timing of repeat screening is individualized according to the polyps found and how well hormone levels are controlled.
Which symptoms after pituitary surgery require urgent medical help?
Seek urgent help for new vision loss or double vision, a severe or worsening headache, clear watery fluid from the nose, fever or neck stiffness, or marked thirst with excessive urination. Vomiting, fainting, confusion, or profound weakness can also signal a serious complication and need prompt assessment.
Why might I still feel unwell when my acromegaly hormone levels are normal?
Joint problems, fatigue, sleep apnea, body-image concerns, anxiety, or depression may continue even when blood tests are in the normal range. Tell your care team, because these issues can be assessed and treated; the AcroQoL questionnaire may help track how acromegaly affects daily life and relationships.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Now that my hormones are in the 'normal' range, how often do I still need to have my IGF-1 and growth hormone checked to ensure I stay in remission?
  2. 2.Which of my current symptoms—like my joint pain or snoring—are likely to improve with treatment, and which should I expect to manage as permanent changes?
  3. 3.Based on my last colonoscopy and current hormone levels, when is the safest time for me to have my next screening?
  4. 4.Do I need a new echocardiogram or sleep study to see if my heart and breathing have improved since my surgery or starting medication?
  5. 5.Can you help me evaluate my risk for vertebral fractures, even if my standard bone density (DEXA) scan looks normal?
  6. 6.How can we address the emotional and psychological toll of this disease, and are there therapists who specialize in patients with chronic endocrine conditions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.

    Giustina A, Barkan A, Beckers A, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(4)) doi:10.1210/clinem/dgz096.

    PMID: 31606735
  2. 2

    Consensus on criteria for acromegaly diagnosis and remission.

    Giustina A, Biermasz N, Casanueva FF, et al.

    Pituitary 2024; (27(1)):7-22 doi:10.1007/s11102-023-01360-1.

    PMID: 37923946
  3. 3

    Postoperative Considerations Following Pituitary Surgery: A Guide for Clinicians.

    Giraldi EA, Ioachimescu AG

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2025; (31(10)):1339-1345 doi:10.1016/j.eprac.2025.06.018.

    PMID: 40581268
  4. 4

    Every Third Male Patient with Acromegaly Recovers from Hypogonadism after Neurosurgical Treatment.

    Derwich-Rudowicz A, Nijakowski K, Biczysko A, et al.

    Journal of clinical medicine 2024; (13(18)) doi:10.3390/jcm13185526.

    PMID: 39337013
  5. 5

    Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors.

    Babu H, Ortega A, Nuno M, et al.

    Neurosurgery 2017; (81(2)):357-366 doi:10.1093/neuros/nyx020.

    PMID: 28368500
  6. 6

    Postoperative Pituitary MRI Findings in Acromegaly: A Pictorial Review.

    Daskareh M, Abbasi F, Emamzadeh N, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(16)) doi:10.3390/diagnostics16162582.

    PMID: 42650985
  7. 7

    Clinical and radiographic assessment of peripheral joints in controlled acromegaly.

    Pelsma ICM, Kroon HM, van Trigt VR, et al.

    Pituitary 2022; (25(4)):622-635 doi:10.1007/s11102-022-01233-z.

    PMID: 35726113
  8. 8

    Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9 years of longitudinal follow-up.

    Pelsma ICM, Biermasz NR, van Furth WR, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(1)):188-200 doi:10.1210/clinem/dgaa747.

    PMID: 33099640
  9. 9

    Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.

    Fatti LM, Cangiano B, Vitale G, et al.

    Pituitary 2019; (22(5)):552-560 doi:10.1007/s11102-019-00966-8.

    PMID: 31032537
  10. 10

    High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly.

    Frara S, Melin Uygur M, di Filippo L, et al.

    The Journal of clinical endocrinology and metabolism 2022; (107(7)):e2843-e2850 doi:10.1210/clinem/dgac183.

    PMID: 35349698
  11. 11

    Vertebral Fractures Associated with Spinal Sagittal Imbalance and Quality of Life in Acromegaly: A Radiographic Study with EOS 2D/3D Technology.

    Cellini M, Biamonte E, Mazza M, et al.

    Neuroendocrinology 2021; (111(8)):775-785 doi:10.1159/000511811.

    PMID: 32980840
  12. 12

    Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?

    Parolin M, Dassie F, Vettor R, et al.

    Journal of endocrinological investigation 2021; (44(2)):209-221 doi:10.1007/s40618-020-01343-0.

    PMID: 32632903
  13. 13

    Hypertension and Acromegaly.

    Puglisi S, Terzolo M

    Endocrinology and metabolism clinics of North America 2019; (48(4)):779-793 doi:10.1016/j.ecl.2019.08.008.

    PMID: 31655776
  14. 14

    The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study.

    De Alcubierre D, Feola T, Cozzolino A, et al.

    Pituitary 2024; (27(4)):416-427 doi:10.1007/s11102-024-01403-1.

    PMID: 38847918
  15. 15

    Increased Risk of Persistent Glucose Disorders After Control of Acromegaly.

    Rochette C, Graillon T, Albarel F, et al.

    Journal of the Endocrine Society 2017; (1(12)):1531-1539 doi:10.1210/js.2017-00334.

    PMID: 29308447
  16. 16

    The Course of Obstructive Sleep Apnea Syndrome in Patients With Acromegaly During Treatment.

    Wolters TLC, Roerink SHPP, Drenthen LCA, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(1)) doi:10.1210/clinem/dgz050.

    PMID: 31612224
  17. 17

    Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

    Pivonello R, Auriemma RS, Grasso LF, et al.

    Pituitary 2017; (20(1)):46-62 doi:10.1007/s11102-017-0797-7.

    PMID: 28224405
  18. 18

    Growth hormone and gastrointestinal malignancy: An intriguing link.

    Palui R, Sridharan K, Kamalanathan S, et al.

    World journal of gastrointestinal pathophysiology 2023; (14(1)):1-11 doi:10.4291/wjgp.v14.i1.1.

    PMID: 36743656
  19. 19

    Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case-control study.

    Battistone MF, Miragaya K, Rogozinski A, et al.

    Pituitary 2021; (24(1)):96-103 doi:10.1007/s11102-020-01090-8.

    PMID: 33057946
  20. 20

    Acromegaly and Colorectal Neoplasm: An Update.

    Kasuki L, Maia B, Gadelha MR

    Frontiers in endocrinology 2022; (13()):924952 doi:10.3389/fendo.2022.924952.

    PMID: 35795151
  21. 21

    Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study.

    Pivonello R, Auriemma RS, Delli Veneri A, et al.

    European journal of endocrinology 2022; (187(6)):823-845 doi:10.1530/EJE-22-0263.

    PMID: 36165745
  22. 22

    Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life.

    Geraedts VJ, Dimopoulou C, Auer M, et al.

    Frontiers in endocrinology 2014; (5()):229 doi:10.3389/fendo.2014.00229.

    PMID: 25610427
  23. 23

    Quality of life in patients with acromegaly receiving lanreotide autogel: a real-world observational study.

    Bolanowski M, Hubalewska-Dydejczyk A, Kos-Kudła B, et al.

    Endokrynologia Polska 2021; (72(5)):512-519 doi:10.5603/EP.a2021.0075.

    PMID: 34647602
  24. 24

    State of the Art of Patient-reported Outcomes in Acromegaly or GH Deficiency: A Systematic Review and Meta-analysis.

    van der Meulen M, Zamanipoor Najafabadi AH, Broersen LHA, et al.

    The Journal of clinical endocrinology and metabolism 2022; (107(5)):1225-1238 doi:10.1210/clinem/dgab874.

    PMID: 34871425

This page is for informational purposes only and does not constitute medical advice. Your endocrinology and surgical teams should tailor urgent-care instructions and long-term monitoring to your symptoms, test results, and treatment history.

Get notified when new evidence is published on growth hormone-producing pituitary gland neoplasm.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.